UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $174,000 | +70.6% | 10,318 | +97.1% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -89.9% | 5,235 | -90.7% | 0.00% | -80.0% |
| Q4 2020 | $1,014,000 | -14.9% | 56,244 | -8.9% | 0.01% | -37.5% |
| Q3 2020 | $1,191,000 | -65.4% | 61,736 | -53.1% | 0.01% | -72.4% |
| Q2 2020 | $3,439,000 | +89.8% | 131,650 | +29.6% | 0.03% | +70.6% |
| Q1 2020 | $1,812,000 | +7.9% | 101,597 | +101.8% | 0.02% | +13.3% |
| Q4 2019 | $1,680,000 | +41.7% | 50,340 | +1.2% | 0.02% | +50.0% |
| Q3 2019 | $1,186,000 | – | 49,755 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |